← All trials
NCT00918320
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2009
- Primary completion
- Oct 1, 2013
- Completion date
- Aug 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 129
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Institut Gustave RoussyLead sponsor
- St. Anna KinderkrebsforschungCollaborator
- Catholic University of Sacred Heart, RomeCollaborator
- Institut Gustave RoussyOverall official - principal investigator
- Erasmus University RotterdamCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.